Are antidepressants safe in patients with coronary heart disease?

April 19, 2018, Journal of Psychotherapy and Psychosomatics

An investigation published in the current issue of Psychotherapy and Psychosomatics explores the cardiac events that may occur with the use of antidepressant drugs in coronary artery disease. The aim of this study was assessing the use of antidepressants by class in relation to cardiology practice recommendations, and the association of antidepressant use with the occurrence of major adverse cardiovascular events including death.

This is a historical cohort study of all patients who completed cardiac rehabilitation between 2002 and 2012 in a major CR center. Participants completed the Patient Health Questionnaire (PHQ-9) at the start and end of the program. A linkage system enabled ascertainment of antidepressant use and MACE through 2014. Of the 1,694 CR participants, 1,266 (74.7%) completed the PHQ-9 after the program. Depressive symptoms decreased significantly from pre- to post-program (p < 0.001). Overall, 433 (34.2%) participants were on antidepressants, most often selective serotonin reuptake inhibitors (SSRI; n = 299; 23.6%).

The proportion of days covered was approximately 70% for all 4 major antidepressant classes; discontinuation rates ranged from 37.3% for tricyclics to 53.2% for (SNRI). Antidepressant use was significantly associated with lower after cardiac rehabilitation (p < 0.001). After a median follow-up of 4.7 years, 264 (20.9%) participants had a major adverse cardiovascular event. After propensity matching based on pre- depressive symptoms among other variables, participants taking tricyclics had significantly more major adverse cardiovascular events than those not taking tricyclics, as well as those taking atypicals versus not and those on SSRI. There was no increased risk with use of SNRI.

These findings suggest that the use of antidepressants was associated with lower depression, but the use of all antidepressants except SNRI was associated with more .

Explore further: Low risk of serotonin syndrome for triptans + SSRI/SNRI

More information: Sherry L. Grace et al. Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease, Psychotherapy and Psychosomatics (2018). DOI: 10.1159/000486794

Related Stories

Low risk of serotonin syndrome for triptans + SSRI/SNRI

February 27, 2018
(HealthDay)—A low risk of serotonin syndrome is seen in association with concomitant use of triptans and selective serotonin reuptake inhibitor (SSRI) or selective norepinephrine reuptake inhibitor (SNRI) antidepressants, ...

The cardiovascular risk of antidepressant drugs—new data

October 17, 2017
Antidepressants are commonly prescribed medications, but their long-term health effects are debated. Antidepressants disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing ...

Antidepressants associated with significantly elevated risk of death, researchers find

September 14, 2017
Antidepressant medications, most commonly prescribed to reduce depression and anxiety, increase the risk of death, according to new findings by a McMaster-led team of researchers.

Depression, antidepressant use may up risk of A-fib

March 23, 2018
(HealthDay)—Depression and antidepressant use are associated with atrial fibrillation (AF), according to a study presented at the American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health ...

Antidepressant use associated with increased mortality among critically ill patients?

May 22, 2012
Researchers at Beth Israel Deaconess Medical Center, in Boston, and the Massachusetts Institute of Technology in Cambridge, have found that critically ill patients were more likely to die if they were taking the most commonly ...

SSRI antidepressants not associated with an increased risk cardiovascular conditions

March 22, 2016
Commonly used antidepressants, known as 'selective serotonin reuptake inhibitors', are not associated with an increased risk of cardiovascular conditions, such as heart attacks and strokes, according to new research at The ...

Recommended for you

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

FDA approves brain stimulation device for OCD

August 17, 2018
(HealthDay)—A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing Friday by the U.S. Food and Drug Administration.

Research eyes role of stress in mental illnesses

August 17, 2018
We all face stress in our lives. Even researchers seeking to understand why some people shrug it off while others face battles against disorders like depression or PTSD.

16 going on 66: Will you be the same person 50 years from now?

August 17, 2018
How much do you change between high school and retirement? The answer depends on whether you're comparing yourself to others or to your younger self.

Men and women show surprising differences in seeing motion

August 16, 2018
Researchers reporting in the journal Current Biology on August 16 have found an unexpected difference between men and women. On average, their studies show, men pick up on visual motion significantly faster than women do.

It's okay when you're not okay: Study re-evaluates resilience in adults

August 16, 2018
Adversity is part of life: Loved ones die. Soldiers deploy to war. Patients receive terminal diagnoses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.